Genevieve Kanter of the Perelman School of Medicine described three potential scenarios for updates to the COVID-19 vaccine. The FDA could require a new emergency use authorization (EUA), it could allow amendments to the existing EUA, or the original vaccines could have enough data to achieve full FDA approval by the time an update is needed, she said.

February 11, 2021 ・ From NPR